HSV gene therapy (Chiron Viagene)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NameHSV gene therapy (Chiron Viagene)
Drug Alias NameN/A
ClassificationCell and gene therapy > Gene therapy > Viral vector-based gene therapy > Retroviral vector
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsHerpes Simplex
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesChiron Viagene Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesChiron Viagene Inc
Active IndicationsN/A
Inactive IndicationsHerpes Simplex

Other Information

ATC CodeN/A
Related LinksN/A